USPTO serial 79325765
MTRYPAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 5, 2023
- Examiner
- AGREDA, SAMANTHA LEIGH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MTRYPAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sandra Lex
Sandra Lex Mendelsohn Dunleavy, P.C.1500 JFK Blvd.Two Penn Center, Suite 910Philadelphia, PA 19102Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products and medical products, namely blood for medical purposes; medical preparations, namely blood for medical purposes; pharmaceutical proteins and medical protein preparations made from human blood, blood plasma and blood serum, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins, all being pharmaceutical preparations for preventing and treating of immune system related diseases and disorders, neurological diseases and disorders, cancer, infections; pharmaceutical preparations for immunology, neurology, intensive medicine, transplantation medicine, oncology, namely pharmaceutical preparations for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and disorders, cancer, and infections; pharmaceutical preparations for preventing and treating viral diseases, diseases of the immune system, autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying or toxin-neutralizing medicines, namely pharmaceutical preparations for treatment of immune-related diseases and disorders, for treatment of allergies, and for treatment of infections | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 26, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 6, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 5, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 5, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 5, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 5, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 30, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 30, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 30, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 17, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 17, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 17, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 17, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 9, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 19, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 19, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 31, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 31, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 31, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 29, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 26, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 2, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 2, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 25, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 24, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 23, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 18, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |